Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to prevent diseases and lengthen healthspan—the period of life spent in good health. 

As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

To date, we have more than a dozen programs (PipeCos) in our pipeline, including Amplifier Therapeutics (developing a peripherally restricted pan-AMPK activator for the treatment of cardiometabolic diseases), Tornado Therapeutics (developing safer, more effective mTOR inhibitors for extended healthspan), and our latest addition, Telos Biotech (enhancing cell therapies to overcome senescence and exhaustion). We also has programs focused on Women’s Health and Aging (Oviva Therapeutics), Fibrosis (Isterian Biotech), and cellular engineering (Vita Therapeutics).

Sensei Biotherapeutics

Arcellx

Delphi VC

FJ Labs

Mount Nebo Investments LLC

NJF Capital

Infinitas Capital

Korify Capital

Mike Novogratz

Sprint Vc

SALT Fund

Future Ventures

Alumni Ventures

Anthos Capital

Apeiron Investment Group

Kliwla Family Office AG

Moore Capital

Cambrian Bio

Buffalo BioLabs is a biotechnology company focused on drug development and research in the biopharmaceutical industry.

Buffalo BioLabs

KSL Diagnostics is a company specializing in diagnostic solutions and technologies for the healthcare industry.

KSL Diagnostics

Genencor International is a biotechnology company that focuses on developing and commercializing biologically-derived therapeutic drugs.

Genencor International

Eloxx Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of novel therapeutics for the treatment of genetic diseases.

Eloxx Pharmaceuticals Inc

Novartis AG is a multinational pharmaceutical company that develops and manufactures a wide range of healthcare products and pharmaceuticals.

Novartis AG

Spruce Biosciences Inc is a biopharmaceutical company focused on developing novel therapies for rare endocrine disorders.

Spruce Biosciences Inc

Pappas Ventures companies are involved in investing in and supporting innovative biotechnology and life sciences companies.

Pappas Ventures companies

Precision BioSciences is a biotechnology company focused on developing gene editing and gene therapy technologies for various applications.

Precision BioSciences

Immunitas Therapeutics is a biotechnology company specializing in the development of immunotherapies for cancer and autoimmune diseases.

Immunitas Therapeutics

Felix is a drug discovery company that utilizes advanced technologies to identify and develop novel therapeutics for various diseases.

Felix (Drug Discovery)

Neurona Therapeutics is a biotechnology company focused on developing stem cell-based therapies for neurological disorders.

Neurona Therapeutics

Poseida Therapeutics is a biotechnology company specializing in the development of gene therapies for the treatment of genetic diseases and cancer.

Poseida Therapeutics

Cellular Approaches is a biotechnology company focused on developing cellular therapies for the treatment of various diseases.

Cellular Approaches

Park Place Senior Living is a company providing senior living and healthcare services for the elderly population.

Park Place Senior Living

Outlook Therapeutics is a biopharmaceutical company focused on developing ophthalmic therapies for the treatment of eye diseases.

Outlook Therapeutics

Cambrian Biopharma is a therapeutics company focused on developing transformative medicines by leveraging the power of biotechnology. It operates as a pipeline company, advancing novel treatments through clinical trials. Cambrian Bio's approach involves creating and supporting multiple therapeutic companies, each targeting different areas of high unmet medical need.

Cambrian Biopharma

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 6:47 AM	c5063aa1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 16, 2024 6:47 AM	0b43895f
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:CAMBRIANBIO

Cambrian Biopharma